[Federal Register Volume 68, Number 13 (Tuesday, January 21, 2003)]
[Notices]
[Page 2784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-1208]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on February 20, 2003, from 
8:30 a.m. to 4:30 p.m.
    Location: Holiday Inn, 8120 Wisconsin Ave., Bethesda, MD.
    Contact Person: Jody G. Sachs or Denise H. Royster, Center for 
Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12391. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will review and discuss the selection of 
strains to be included in the influenza virus vaccine for the 2003-2004 
season and the intramural research program of the Laboratory of 
Bacterial Polysaccharides, Office of Vaccines Research and Review.
    Procedure: On February 20, 2003, from 8:30 a.m. to 3:20 p.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
February 4, 2003. Oral presentations from the public will be scheduled 
between approximately 1 p.m. and 1:30 p.m. and 2:50 p.m. and 3:20 p.m. 
Time allotted for each presentation may be limited. Those desiring to 
make formal oral presentations should notify the contact person before 
February 4, 2003, and submit a brief statement of the general nature of 
the evidence or arguments they wish to present, the names and addresses 
of proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Closed Committee Deliberations: On February 20, 2003, from 3:20 
p.m. to 4:30 p.m., the meeting will be closed to permit discussion 
where disclosure would constitute a clearly unwarranted invasion of 
personal privacy (5 U.S.C. 552b(c)(6)).
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jody G. Sachs or 
Denise H. Royster at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: January 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-1208 Filed 1-17-03; 8:45 am]
BILLING CODE 4160-01-S